Cargando…
P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429742/ http://dx.doi.org/10.1097/01.HS9.0000968964.32175.7d |
_version_ | 1785090787629858816 |
---|---|
author | Lachowiez, Curtis Zettler, Christina Barcellos, Anna Belli, Andrew Fernandes, Laura Hansen, Eric Wang, Ching-Kun Swords, Ronan |
author_facet | Lachowiez, Curtis Zettler, Christina Barcellos, Anna Belli, Andrew Fernandes, Laura Hansen, Eric Wang, Ching-Kun Swords, Ronan |
author_sort | Lachowiez, Curtis |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104297422023-08-17 P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY Lachowiez, Curtis Zettler, Christina Barcellos, Anna Belli, Andrew Fernandes, Laura Hansen, Eric Wang, Ching-Kun Swords, Ronan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429742/ http://dx.doi.org/10.1097/01.HS9.0000968964.32175.7d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Lachowiez, Curtis Zettler, Christina Barcellos, Anna Belli, Andrew Fernandes, Laura Hansen, Eric Wang, Ching-Kun Swords, Ronan P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY |
title | P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY |
title_full | P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY |
title_fullStr | P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY |
title_full_unstemmed | P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY |
title_short | P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY |
title_sort | p514: treatment patterns and real-world outcomes of molecular subgroups in patients with acute myeloid leukemia receiving frontline venetoclax-based therapy |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429742/ http://dx.doi.org/10.1097/01.HS9.0000968964.32175.7d |
work_keys_str_mv | AT lachowiezcurtis p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy AT zettlerchristina p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy AT barcellosanna p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy AT belliandrew p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy AT fernandeslaura p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy AT hanseneric p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy AT wangchingkun p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy AT swordsronan p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy |